Search

Your search keyword '"Papenfuss, Mary R."' showing total 34 results
Start Over Author "Papenfuss, Mary R."
34 results on '"Papenfuss, Mary R."'

4. Supplementary Table 1 from Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study

Author

Schabath, Matthew B., primary, Villa, Luisa L., primary, Lin, Hui-Yi, primary, Fulp, William J., primary, Akogbe, Gabriel O., primary, Abrahamsen, Martha E., primary, Papenfuss, Mary R., primary, Lazcano-Ponce, Eduardo, primary, Salmerón, Jorge, primary, Quiterio, Manuel, primary, and Giuliano, Anna R., primary

Published
2023
Full Text
View/download PDF

11. HPV 6/11, 16, 18 Seroprevalence in Men in Two US Cities

Author

Dunne, Eileen F., Nielson, Carrie M., Hagensee, Michael E., Papenfuss, Mary R., Harris, Robin B., Herrel, Nicholas, Gourlie, Jennifer, Abrahamsen, Martha, Markowitz, Lauri E., and Giuliano, Anna R.

Published
2009

23. Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study

Author

Albero Ginesa, Villa Luisa L, Lazcano-Ponce Eduardo, Fulp William, Papenfuss Mary R, Nyitray Alan G, Lu Beibei, Castellsagué Xavier, Abrahamsen Martha, Smith Danélle, Bosch F Xavier, Salmerón Jorge, Quiterio Manuel, and Giuliano Anna R

Subjects
Male circumcision, Genital, HPV, Non-oncogenic, Prevalence, Infectious and parasitic diseases, RC109-216
Abstract

Abstract Background Accumulated evidence from epidemiological studies and more recently from randomized controlled trials suggests that male circumcision (MC) may substantially protect against genital HPV infection in men. The purpose of this study was to assess the association between MC and genital HPV infection in men in a large multinational study. Methods A total of 4072 healthy men ages 18–70 years were enrolled in a study conducted in Brazil, Mexico, and the United States. Enrollment samples combining exfoliated cells from the coronal sulcus, glans penis, shaft, and scrotum were analyzed for the presence and genotyping of HPV DNA by PCR and linear array methods. Prevalence ratios (PR) were used to estimate associations between MC and HPV detection adjusting for potential confounders. Results MC was not associated with overall prevalence of any HPV, oncogenic HPV types or unclassified HPV types. However, MC was negatively associated with non-oncogenic HPV infections (PR 0.85, 95% confident interval: 0.76-0.95), in particular for HPV types 11, 40, 61, 71, and 81. HPV 16, 51, 62, and 84 were the most frequently identified genotypes regardless of MC status. Conclusions This study shows no overall association between MC and genital HPV infections in men, except for certain non-oncogenic HPV types for which a weak association was found. However, the lack of association with MC might be due to the lack of anatomic site specific HPV data, for example the glans penis, the area expected to be most likely protected by MC.

Published
2013
Full Text
View/download PDF

26. Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study

Author

Schabath, Matthew B., primary, Villa, Luisa L., additional, Lin, Hui-Yi, additional, Fulp, William J., additional, Akogbe, Gabriel O., additional, Abrahamsen, Martha E., additional, Papenfuss, Mary R., additional, Lazcano-Ponce, Eduardo, additional, Salmerón, Jorge, additional, Quiterio, Manuel, additional, and Giuliano, Anna R., additional

Published
2013
Full Text
View/download PDF

28. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men

Author

Lu, Beibei, primary, Viscidi, Raphael P., additional, Wu, Yougui, additional, Lee, Ji-Hyun, additional, Nyitray, Alan G., additional, Villa, Luisa L., additional, Lazcano-Ponce, Eduardo, additional, da Silva, Roberto J. Carvalho, additional, Baggio, Maria Luiza, additional, Quiterio, Manuel, additional, Salmeron, Jorge, additional, Smith, Danelle C., additional, Abrahamsen, Martha E., additional, Papenfuss, Mary R., additional, Stockwell, Heather G., additional, and Giuliano, Anna R., additional

Published
2012
Full Text
View/download PDF

30. The Human Papillomavirus Infection in Men Study: Human Papillomavirus Prevalence and Type Distribution among Men Residing in Brazil, Mexico, and the United States

Author

Giuliano, Anna R., primary, Lazcano-Ponce, Eduardo, additional, Villa, Luisa L., additional, Flores, Roberto, additional, Salmeron, Jorge, additional, Lee, Ji-Hyun, additional, Papenfuss, Mary R., additional, Abrahamsen, Martha, additional, Jolles, Emily, additional, Nielson, Carrie M., additional, Baggio, Maria Luisa, additional, Silva, Roberto, additional, and Quiterio, Manuel, additional

Published
2008
Full Text
View/download PDF

34. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men.

Author

Beibei Lu, Viscidi, Raphael P., Yougui Wu, Ji-Hyun Lee, Nyitray, Alan G., Villa, Luisa L., Lazcano-Ponce, Eduardo, da Silva, Roberto J. Carvalho, Baggio, Maria Luiza, Quiterio, Manuel, Salmeron, Jorge, Smith, Danelle C., Abrahamsen, Martha E., Papenfuss, Mary R., Stockwell, Heather G., and Giuliano, Anna R.

Subjects
*PAPILLOMAVIRUS diseases, *VIRUS diseases, *CANCER, *TUMORS, *INFECTION
Abstract

In women, naturally induced anti-human papilloma virus (HPV) serum antibodies are a likely marker of host immune protection against subsequent HPV acquisition and progression to precancerous lesions and cancers. However, it is unclear whether the same is the case in men. In this study, we assessed the risk of incident genital infection and 6-month persistent genital infection with HPV16 in relation to baseline serostatus in a cohort of 2,187 men over a 48-month period. Genital swabs were collected every 6 months and tested for HPV presence. Incidence proportions by serostatus were calculated at each study visit to examine whether potential immune protection attenuated over time. Overall, incidence proportions did not differ statistically between baseline seropositive and seronegative men at any study visit or over the follow-up period. The risk of incident and 6-month persistent infection was not associated with baseline serostatus or baseline serum antibody levels in the cohort. Our findings suggest that baseline HPV seropositivity in men is not associated with reduced risk of subsequent HPV16 acquisition. Thus, prevalent serum antibodies induced by prior infection may not be a suitable marker for subsequent immune protection against genital HPV16 acquisition in men. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results